NCT05425979
Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentMayo ClinicInvestigator-initiated
~50 participants
Updated 2025-08-11 on ClinicalTrials.gov
What's tested:MepivacaineBupivacaine
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Onset of sensory Blockage
Measured over 20 minutes
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Bridget Pulos, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age greater than or equal to 18 years old.
Patients who provide informed consent to participate.
Patients undergoing foot surgery who require a peripheral nerve block of the ankle as primary anesthesia.
ASA (American Society of Anesthesiology) Physical Status Classification I - III.
Exclusion
Inability to consent.
Allergy to local anesthetic.
Infection at site of injection.
Pregnancy.
Coagulopathy.
Hepatic or renal failure.
Preexisting neuropathy in operative limb.
Planned spinal anesthetic or general anesthesia.
What this trial measures
- Onset of sensory Blockage20 minutes
Time in minutes for successful surgical sensory blockade following the ankle block